stoxline Quote Chart Rank Option Currency Glossary
  
Fortrea Holdings Inc. (FTRE)
24.7  -0.13 (-0.52%)    06-13 16:00
Open: 24.81
High: 25
Volume: 908,954
  
Pre. Close: 24.83
Low: 24.22
Market Cap: 2,208(M)
Technical analysis
2024-06-13 4:43:30 PM
Short term     
Mid term     
Targets 6-month :  36.85 1-year :  42.17
Resists First :  31.55 Second :  36.11
Pivot price 25.47
Supports First :  24.18 Second :  20.11
MAs MA(5) :  25.34 MA(20) :  25.85
MA(100) :  33.93 MA(250) :  0
MACD MACD :  -1.9 Signal :  -2.2
%K %D K(14,3) :  20.1 D(3) :  28.5
RSI RSI(14): 32.7
52-week High :  41.02 Low :  24.18
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ FTRE ] has closed above bottom band by 29.3%. Bollinger Bands are 34.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 25.16 - 25.4 25.4 - 25.55
Low: 23.71 - 24.02 24.02 - 24.21
Close: 24.34 - 24.85 24.85 - 25.17
Company Description

Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. It operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is based in Durham, North Carolina.

Headline News

Thu, 13 Jun 2024
Gates Capital Management Inc. Makes New $67.86 Million Investment in Fortrea Holdings Inc. (NASDAQ:FTRE) - MarketBeat

Thu, 13 Jun 2024
Fortrea (FTRE) and Its Rivals Financial Review - Defense World

Wed, 12 Jun 2024
James S. Hanson Purchases 2,000 Shares of Fortrea Holdings Inc. (NASDAQ:FTRE) Stock - MarketBeat

Wed, 12 Jun 2024
Reviewing Laboratory Co. of America (NYSE:LH) & Fortrea (NASDAQ:FTRE) - Defense World

Tue, 11 Jun 2024
CIBC Asset Management Inc Takes Position in Fortrea Holdings Inc. (NASDAQ:FTRE) - Defense World

Mon, 10 Jun 2024
Fortrea (NASDAQ:FTRE) Shares Down 4.3% - MarketBeat

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 89 (M)
Shares Float 77 (M)
Held by Insiders 0.1 (%)
Held by Institutions 106.7 (%)
Shares Short 5,670 (K)
Shares Short P.Month 4,660 (K)
Stock Financials
EPS -1.02
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 17.8
Profit Margin -3.8 %
Operating Margin -5.2 %
Return on Assets (ttm) 0.5 %
Return on Equity (ttm) -3.7 %
Qtrly Rev. Growth -4.6 %
Gross Profit (p.s.) 0
Sales Per Share 34.46
EBITDA (p.s.) 1.52
Qtrly Earnings Growth 0 %
Operating Cash Flow 144 (M)
Levered Free Cash Flow 207 (M)
Stock Valuations
PE Ratio -24.22
PEG Ratio -4.4
Price to Book value 1.38
Price to Sales 0.71
Price to Cash Flow 15.35
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android